An initiative to advance the development and commercialisation of medical devices, including T-TAS, aimed at reducing the risks of thrombosis and bleeding, and develop this as a next-generation earnings platform. It is also linked to the establishment of a contract manufacturing platform for in-vitro diagnostic-related medical devices and cell-related products.